Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 12
2013 9
2014 12
2015 13
2016 5
2017 5
2018 3
2019 2
2020 1
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.
Xiang J, Lu M, Shi M, Cheng X, Kwakwa KA, Davis JL, Su X, Bakewell SJ, Zhang Y, Fontana F, Xu Y, Veis DJ, DiPersio JF, Ratner L, Sanderson RD, Noseda A, Mollah S, Li J, Weilbaecher KN. Xiang J, et al. J Virol. 2022 Apr 13;96(7):e0005722. doi: 10.1128/jvi.00057-22. Epub 2022 Mar 23. J Virol. 2022. PMID: 35319225 Free PMC article.
Targeted Therapy to β3 Integrin Reduces Chemoresistance in Breast Cancer Bone Metastases.
Fox GC, Su X, Davis JL, Xu Y, Kwakwa KA, Ross MH, Fontana F, Xiang J, Esser AK, Cordell E, Pagliai K, Dang HX, Sivapackiam J, Stewart SA, Maher CA, Bakewell SJ, Fitzpatrick JAJ, Sharma V, Achilefu S, Veis DJ, Lanza GM, Weilbaecher KN. Fox GC, et al. Mol Cancer Ther. 2021 Jun;20(6):1183-1198. doi: 10.1158/1535-7163.MCT-20-0931. Epub 2021 Mar 30. Mol Cancer Ther. 2021. PMID: 33785647 Free PMC article.
VLA4-Targeted Nanoparticles Hijack Cell Adhesion-Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival.
Fontana F, Scott MJ, Allen JS, Yang X, Cui G, Pan D, Yanaba N, Fiala MA, O'Neal J, Schmieder-Atteberry AH, Ritchey J, Rettig M, Simons K, Fletcher S, Vij R, DiPersio JF, Lanza GM. Fontana F, et al. Clin Cancer Res. 2021 Apr 1;27(7):1974-1986. doi: 10.1158/1078-0432.CCR-20-2839. Epub 2020 Dec 22. Clin Cancer Res. 2021. PMID: 33355244 Free PMC article.
HTLV-1 viral oncogene HBZ drives bone destruction in adult T cell leukemia.
Xiang J, Rauch DA, Huey DD, Panfil AR, Cheng X, Esser AK, Su X, Harding JC, Xu Y, Fox GC, Fontana F, Kobayashi T, Su J, Sundaramoorthi H, Wong WH, Jia Y, Rosol TJ, Veis DJ, Green PL, Niewiesk S, Ratner L, Weilbaecher KN. Xiang J, et al. JCI Insight. 2019 Oct 3;4(19):e128713. doi: 10.1172/jci.insight.128713. JCI Insight. 2019. PMID: 31578308 Free PMC article.
HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice.
Esser AK, Rauch DA, Xiang J, Harding JC, Kohart NA, Ross MH, Su X, Wu K, Huey D, Xu Y, Vij K, Green PL, Rosol TJ, Niewiesk S, Ratner L, Weilbaecher KN. Esser AK, et al. Oncotarget. 2017 Aug 27;8(41):69250-69263. doi: 10.18632/oncotarget.20565. eCollection 2017 Sep 19. Oncotarget. 2017. PMID: 29050201 Free PMC article.
Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases.
Ross MH, Esser AK, Fox GC, Schmieder AH, Yang X, Hu G, Pan D, Su X, Xu Y, Novack DV, Walsh T, Colditz GA, Lukaszewicz GH, Cordell E, Novack J, Fitzpatrick JAJ, Waning DL, Mohammad KS, Guise TA, Lanza GM, Weilbaecher KN. Ross MH, et al. Cancer Res. 2017 Nov 15;77(22):6299-6312. doi: 10.1158/0008-5472.CAN-17-1225. Epub 2017 Aug 30. Cancer Res. 2017. PMID: 28855208 Free PMC article.
An unmet clinical need: The history of thrombus imaging.
Lanza GM, Cui G, Schmieder AH, Zhang H, Allen JS, Scott MJ, Williams T, Yang X. Lanza GM, et al. J Nucl Cardiol. 2019 Jun;26(3):986-997. doi: 10.1007/s12350-017-0942-8. Epub 2017 Jun 12. J Nucl Cardiol. 2019. PMID: 28608182 Free PMC article. Review.
52 results